MedPath

Arizona Alzheimer's Disease Research Center (ADRC)

Recruiting
Conditions
Alzheimer Disease
Registration Number
NCT05405075
Lead Sponsor
Banner Health
Brief Summary

The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, the basic, cognitive and behavioral neurosciences, clinical, and neuropathological studies of AD, the discovery and evaluation of investigational treatments, and the study of normal cognitive aging.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
550
Inclusion Criteria
  • Cognitively normal persons, individuals with mild cognitive impairment or dementia who are at least 40 years of age.
  • Willing to undergo health and cognitive assessments, and collection and banking of blood with venipuncture for genetic research, biomarker research, and DNA banking.
Exclusion Criteria
    1. Participants whose diagnosis is unclear and confounded by multiple possible factors are excluded. Participants with diagnoses of non-AD dementias are not excluded.

    2. Participants whose primary diagnosis is cognitive impairment due to a penetrating or single severe closed head injury, multiple sclerosis, brain tumor, metabolic or toxic encephalopathy, post-infectious (e.g., viral encephalitis, bacterial meningitis), paraneoplastic, primary psychiatric illness, or otherwise not deemed relevant to the intent of the Alzheimer Disease Center program are excluded.

    3. Procedure specific exclusion criteria also apply but this does not impact the participants ability to be included in the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive Status12 months

The ADRC uses a prospective, standardized, and longitudinal clinical evaluation of participants to determine their cognitive status. This includes tests that assess short and long term memory, ability to complete daily tasks, and processing of information.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Banner Sun Health Research Institute

🇺🇸

Sun City, Arizona, United States

Banner Alzheimer's Institute - Tucson

🇺🇸

Tucson, Arizona, United States

Mayo Clinic

🇺🇸

Scottsdale, Arizona, United States

Banner Alzheimer's Institute

🇺🇸

Phoenix, Arizona, United States

Barrow Neurological Institute

🇺🇸

Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath